C-CAR088
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for C-CAR088, covering 2025-10-01 to 2025-10-01. Get the full timeline:
Most recent: Clinical Trial Update: ASCT in Combination With C-CAR088 for Treating Patients With Ultra High-risk Multiple Myeloma (MM) [Phase 1, Phase 2]